N

Novyra Pharmachem Limited

BANSTEA
Market snapshot · 2026-08-11 05:25 UTC

10.70

₹0.00 (+0.00%)

MARKET CAP

₹6.77 Cr

STOCK P/E

52W HIGH

₹16.55

52W LOW

₹5.60

BOOK VALUE

₹0.98

EPS

ROE

-162.40%

SECTOR

Consumer Defensive

DEBT/EQUITY

VOLUME

100

P/B RATIO

10.89x

PEG RATIO

Sector

Consumer Defensive

Themes

Farm Products
₹15.86₹13.30₹10.73₹8.17₹5.60VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Overvalued

5Y Average

43.33

Current

64.88

Overvalued

50.66

Undervalued

26.51

P/B
Undervalued

5Y Average

Current

10.89

Overvalued

12.52

Undervalued

9.25

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.10 CrMar 2026

Latest net profit

₹-5.34 CrMar 2026

Latest EPS

₹-8.44Mar 2026

Net margin

-5330.0%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-5332.0%-5331.0%-5330.0%-5329.0%-5328.0%-6.00 Cr-4.00 Cr-2.00 Cr0.00 Cr2.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr0.03 Cr0.05 Cr0.07 Cr0.10 Cr₹-9₹-6₹-3₹0₹3
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-6.00 Cr-4.00 Cr-2.00 Cr0.00 Cr2.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-3.00 Cr0.00 Cr3.00 Cr6.00 Cr9.00 Cr
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.040.000.000.000.000.000.000.000.000.000.000.000.10
Expenses +0.070.050.060.010.020.000.000.010.070.030.000.025.43
Operating Profit-0.03-0.05-0.06-0.01-0.020.000.00-0.01-0.07-0.030.00-0.02-5.33
OPM %-75.00%-5,330.00%
Other Income +0.000.000.000.000.000.000.000.000.050.030.020.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.020.000.000.000.030.010.010.010.01
Profit before tax-0.03-0.05-0.06-0.01-0.040.000.00-0.01-0.05-0.010.01-0.03-5.34
Tax %66.67%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.05-0.05-0.06-0.01-0.040.000.00-0.01-0.05-0.010.01-0.03-5.34
EPS in Rs-0.08-0.08-0.09-0.02-0.060.000.00-0.02-0.08-0.020.02-0.05-8.44
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +23.15%23.15%23.15%23.15%23.15%
Public +76.85%76.85%76.85%76.86%76.86%
Jun 2026
Promoters +
Public +

Events Timeline

Annual Report FY26

FY2026PDFCompany Reports Open

Change Of Website

Aug 04, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 13, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 26, 2026PDFCompany Reports Open

Voting Results AGM

Jun 26, 2026PDFCompany Reports Open